Search This Blog

Monday, April 15, 2024

Organovo's fatty liver disease drug meets main goal in mid-stage study

 Organovo Holdings said on Monday its experimental drug to treat a type of fatty liver disease helped significantly reduce liver fat in a mid-stage study. 

https://finance.yahoo.com/news/organovos-fatty-liver-disease-drug-121338549.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.